-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrThis is encouraging since it is so hard to treat these symptoms. -
Migraine Connect4yrArticle Highlights • Source: Revue Neurologique • Conclusion/Relevance: “[O]ur current clinical trial supports the beneficial effect of resistance exercise in attenuating vestibular symptoms among VM patients, particularly after four months of frequent intervention. Our Show More
Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last?
Source : https://www.scielo.br/j/anp/a/wzVyTfxfBK6PmVQ555ZmL5C/?lang=en
Botulinum toxin Type A (BoNTA) is a successful treatment for chronic migraine prophylaxis. We aimed to evaluate the monthly change of effectiveness of BoNTA treatment. A total of 80 patients...
Conclusion:
In our study, there was a significant reduction in analgesic intake and headache days in the first and second months after BoNTA injection, and an increase was observed in the third month.
-
HAROLD Friend, Boca Neurology LLC4yrWearing off occurs after 10 weeks with Botox. Dysport has a longer effective time, 12-14 weeks usually. -
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrI have seen the wearing off effect starting at 10 weeks. I am not sure that you meant 3rd month?
Show More Comments
Headache and migraine clinical practice guidelines: a systematic review and assessment of complementary and alternative medicine recommendations - BMC Complementary Medicine and Therapies
Source : https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-021-03401-3
Background Globally, 3 billion people suffer from either migraine or tension-type headache disorder over their lifetime. Approximately 50% of American adults suffering from headache or migraine have used complementary and...
Conclusions
Of the eligible CPGs, the CAM sections were of lower quality compared to the overall recommendations across all domains of the AGREE II instrument. CPGs that scored well could serve as a framework for discussion between patients and healthcare professionals regarding use of CAM therapies in the context of headache and migraine.
-
HAROLD Friend, Boca Neurology LLC4yrNeed vigorous studies to know how much is placebo effect and how much is actual treatment effect -
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrComplementary methods are so important.
/>
Meta‐analysis of association between migraine and risk of dementia
Source : https://onlinelibrary.wiley.com/doi/10.1111/ane.13528?af=R
Objectives The association between migraine and dementia has rarely been investigated, and available results are conflicting. Thus, the aim of this meta-analysis was to evaluate whether an associati...
-
Dr Hamid4yrAgree with Dr Shiekh …need other studies -
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrTraditionally there is not thought to be one, so this is somewhat disturbing. Need other studies.
Highlights
There is no specific diagnostic test for migraine
The decreased levels of Treg was observed in migraine patients
Recent preclinical study showed improvement in headache by activation of Treg cells
Peripheral Treg cell population could be a potential biomarker for migraine
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrIt would be great to have a biomarker.
